Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers
Do you escalate the dose in adjuvant pancreatic cancer radiation therapy similar to how many are treating locally advanced disease with dose escalation?
In the adjuvant setting, what boost dose to vascular areas can be safely applied, assuming one has all the tech to reliably breath hold the patient and meets the standard bowel dose constraints used in RTOG 0848 (including care to avoid the jejunostomies from the high dose boost)?
Do you treat to a BED of 70 Gy or higher, e.g. 58-75 Gy in 25-28 fractions?
Answer from: Radiation Oncologist at Community Practice
Thanks for the great insights from Dr. @Christopher H. Crane!
I am wondering if you changed your practice based on the presented RTOG 0848 trial results. There was no interaction with margin status, and it seems that chemoradiation benefit is mostly limited to patients with pN0 disease.
Do y...
Comments
Radiation Oncologist at Memorial Sloan-Kettering Cancer Center
There was a survival benefit in the subgroup of pa...
There was a survival benefit in the subgroup of pa...
Radiation Oncologist at Hôtel Dieu de Lévis - CISSS Chaudière-Appalaches
Great points!! Thank you!
Great points!! Thank you!
Other than the small 1985 GITSG trial, is there an...
Interesting comment.
The data are very limited to be sure, but a meta-a...